) Herpesviruses are associated with a variety of human malignancies, but the molecular mechanisms of cell transformation and tumorigenesis are not known. Immunosuppressed AIDS patients are particularly prone to the complications of herpesvirus-induced tumors. A new human herpesvirus, HHV8, was recently identified in association with Kaposi's sarcoma (KS) in AIDS and other patients. Through sequence analysis the applicant has identified a homolog of the human bcl-2 oncogene-encoded by HHV8. The bcl-2 oncogene was identified at translocation breakpoints characteristic of follicular B cell lymphomas. Bcl-2 contributes to tumorigenesis because it is a potent inhibitor of programmed cell death and can function in a wide variety of cell types that are induced to undergo apoptosis by a broad range of stimuli. However, the mechanism by which bcl-2 blocks cell death is not known. The HHV-8 homolog, designated KSbcl-2, also has anti-apoptotic activity and may cooperate with other factors to facilitate transformation similar to that observed for adenovirus E1b. Preliminary studies on the bcl-2 homolog encoded by herpesvirus saimiri indicate that gamma herpesviruses require an inhibitor of apoptosis to successfully complete the lytic replication cycle, suggesting, at the least, that a herpesvirus bcl-2 homolog facilitates transformation by supporting viral replication. (i) To study the bcl-2 homolog of HHV-8, the applicant will identify and map the KSbcl-2 mRNAs in cultured cells and determine if they are expressed during the lytic cycle, the latent cycle, or both. An antibody generated to KSbcl-2 will be used to confirm protein expression during different phases of the virus life cycle in cultured cells and to determine if KSbcl-2 is expressed in KS tumors. (ii) Heterodimerization by bcl-2 family members regulates their function. Therefore, the applicant will determine which cellular bcl-2 family members interact with KSbcl-2 and how these interactions affect the function of KSbcl-2. (iii) The role of KSbcl-2 in virus infection will be studied by determining if KSBCL-2 can rescue the null plaque phenotype of bcl-2-deficient herpes saimiri. (iv) To further understand the function of KSbcl-2, the applicant seeks to identify cellular proteins that mediate the oncogenic/anti-apoptotic potential of KSbcl-2 using the yeast two-hybrid interactive cloning strategy and direct biochemical approaches.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA073581-02
Application #
2458313
Study Section
Special Emphasis Panel (SRC (C2))
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ivanovska, Iva; Hardwick, J Marie (2005) Viruses activate a genetically conserved cell death pathway in a unicellular organism. J Cell Biol 170:391-9
Irusta, Pablo M; Chen, Ying-bei; Hardwick, J Marie (2003) Viral modulators of cell death provide new links to old pathways. Curr Opin Cell Biol 15:700-5
Hardwick, J M; Bellows, D S (2003) Viral versus cellular BCL-2 proteins. Cell Death Differ 10 Suppl 1:S68-76
Bellows, David S; Howell, Melanie; Pearson, Colin et al. (2002) Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol 76:2469-79
Bellows, D S; Chau, B N; Lee, P et al. (2000) Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74:5024-31
Chau, B N; Cheng, E H; Kerr, D A et al. (2000) Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 6:31-40
Hardwick, J M; Levine, B (2000) Sindbis virus vector system for functional analysis of apoptosis regulators. Methods Enzymol 322:492-508
Hardwick, J M (1998) Viral interference with apoptosis. Semin Cell Dev Biol 9:339-49
Nava, V E; Cheng, E H; Veliuona, M et al. (1997) Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 71:4118-22
Cheng, E H; Nicholas, J; Bellows, D S et al. (1997) A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690-4